Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | SYK | P43405 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.38 |
| ▸ | MAP3K12 | Q12852 | 2/20 | 0.38 |
| ▸ | PDE2A | O00408 | 2/20 | 0.37 |
| ▸ | SLC6A7 | Q99884 | 1/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.36 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14752663 | 0.88 | PRCP (0.56) | PRCPALDH1A1SMN1; SMN2KDM4EMAP3K12 | |
| SCHEMBL14749365 | 0.87 | PRCP (0.60) | PRCPALDH1A1SMN1; SMN2SYKKDM4E | |
| SCHEMBL14749320 | 0.85 | PRCP (0.58) | PRCPALDH1A1SMN1; SMN2SYKKDM4E | |
| SCHEMBL14749316 | 0.85 | PRCP (0.57) | PRCPALDH1A1SMN1; SMN2KDM4EMAP3K12 | |
| SCHEMBL14752561 | 0.83 | PRCP (0.62) | PRCPALDH1A1SMN1; SMN2SYKKDM4E | |
| SCHEMBL14749319 | 0.83 | PRCP (0.57) | PRCPALDH1A1SMN1; SMN2KDM4EMAPT | |
| SCHEMBL14749329 | 0.83 | PRCP (0.59) | PRCPALDH1A1SMN1; SMN2KDM4EMAPT | |
| SCHEMBL12184104 | 0.83 | PRCP (0.51) | PRCPALDH1A1SMN1; SMN2KDM4EMAP3K12 | |
| SCHEMBL12183983 | 0.81 | PRCP (0.64) | PRCPALDH1A1SMN1; SMN2SYKKDM4E | |
| SCHEMBL14749328 | 0.81 | PRCP (0.61) | PRCPALDH1A1SMN1; SMN2MAP3K12MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130059830-A1 | NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS | MERCK SHARP & DOHME CORP | 2013-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059830-A1 | NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS | PRCP, PREP, ENPEP | PRCP 1/4885ALDH1A1 661/4885SMN1; SMN2 4754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.